A practical guide to fit-for-purpose analytical development in an emerging cell therapy landscape
Damian Marshall, Jie Wei, Florian Durst
18 June 2025
Expert Roundtable
Producing MSC-derived cell therapies: workflows, technologies, and case studies
I Malaspina, S Mei, T Ting et al
28 March 2025
Expert Roundtable
Why peer review matters: insights from the scientific community
A Goyal, A Cockroft, P Theocharous et al
28 February 2025
Expert Roundtable
Early-stage analytical development strategies for cell therapy
Ramon Mendoza, Kyle Carter, Seth Peterson
16 January 2025
Expert Roundtable
Preparing for success in gene therapy purification
X Fu, A Sharma, A D Tustian et al
05 December 2024
Expert Roundtable
Preparing for success in gene therapy analytical development
Yan Zhi, Jing Li, Andres Castillo
02 December 2024
Expert Roundtable
iPSC-based therapy dilemmas explored: overcoming hurdles for future success
M Carpenter, L Munsie, K Raineri et al
03 September 2024
Expert Roundtable
Unveiling the critical pathways in AAV potency evaluation and future trends in gene therapy
David Rangel, Guangping Gao, Nathalie Clement
09 August 2024
Expert Roundtable
Smooth cell therapy analytical assay translation from analytical development to QC
H H Adams, I Shestopalov, K Yeung et al
28 February 2024
Expert Roundtable
Fast-tracking gene therapy breakthroughs: discussing the critical role of rapid testing
R Legmann, G Thakur, S Levy et al
05 January 2024
Expert Roundtable
Biological & operational considerations for iPSC-derived cell production
A Mogen, A Fernandez-Perez, J Wang et al
20 December 2023
Expert Roundtable
Current issues & future trends in cryopreservation for advanced therapies
Jason Acker, Allison Hubel, Sean Werner
20 December 2023
Expert Roundtable
Cell culture in immune cell therapies: do more with less
Anastasiya Smith, Josh Ludwig, David Hermanson
08 June 2023
Expert Roundtable
Navigating evolving regulatory CMC guidance in the AAV gene therapy field
M Brewer, A Cockroft, C Fuentes et al
15 May 2023
Expert Roundtable
Accelerating cancer therapies development: the importance of platform, process, and partnership
William Swaney, John (Yoshi) Shyu, Nikhil Tyagi
22 April 2023
Expert Roundtable
Driving the expansion of mRNA into the therapeutic sphere
Alejandro Becerra, Andreas Kuhn, Metin Kurtoglu
10 April 2023
Expert Roundtable
AAV process development & scale-up
Catherine Cancian, Karen Doucette, Reinout Hesselink
07 March 2023
Expert Roundtable
Diagnostic & therapeutic uses for extracellular vesicles: insights into a rapidly evolving field
S Wild, J Correia, A de Fougerolles et al
30 November 2022
Expert Roundtable
Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies
Rupa Pike, Delara Motlagh, Patrick Hanley
05 October 2022
Expert Roundtable
Vaccine development in the COVID-19 era: regulatory challenges & innovation
P Marks, M Cavaleri, C Vinals et al
12 May 2022
Expert Roundtable
Strategies for scaling up and out in gene therapy manufacturing: addressing AAV’s growing pains
Christopher Reardon, Phillip Vermilion, John Yoshi Shyu
22 March 2022
Expert Roundtable